FILER PROFILE · CIK 0001694560

New Enterprise Associates 16, L.P.

10 filings 6 distinct issuers Active 2019-02-22 → 2025-08-18

Track Record

Total filings

2 SCHEDULE · 8 SC

Distinct issuers

60% issuer diversity

Median stake

12.3%

8,349,879 avg shares

AI briefs cached

0/10

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

—

across 0 filings · win rate —

Median 60d

—

across 0 filings · win rate —

Median 90d

—

across 0 filings · win rate —

Median 1y

—

across 0 filings · win rate —

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 10 total

Filed	Form	Issuer	Stake	Shares
2025-08-18	SCHEDULE	Marker Therapeutics, Inc.MRKR	12.60%	1,625,678	view →
2025-08-11	SCHEDULE	Trevi Therapeutics, Inc.TRVI	12.00%	15,074,080	view →
2022-01-05	SC	Metacrine, Inc.	—	—	view →
2021-04-14	SC	GENOCEA BIOSCIENCES, INC.	—	—	view →
2021-03-26	SC	Marker Therapeutics, Inc.MRKR	—	—	view →
2021-03-11	SC	Allakos Inc.	—	—	view →
2020-08-03	SC	GENOCEA BIOSCIENCES, INC.	—	—	view →
2020-04-16	SC	Trevi Therapeutics, Inc.TRVI	—	—	view →
2019-05-28	SC	X4 Pharmaceuticals, IncXFOR	—	—	view →
2019-02-22	SC	GENOCEA BIOSCIENCES, INC.	—	—	view →

Alert me when New Enterprise Associates 16, L.P. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.

Request a pilot →